Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Interventional cardiologists' attitudes towards pharmacogenetic testing and impact on antiplatelet prescribing decisions.

Personalized medicine - 1 Jan 2022

Hoffecker Glenda, Kanter Genevieve P, Xu Yao, Matthai William, Kolansky Daniel M, Giri Jay, Tuteja Sony

Abstract excerpt

Aim: To determine if interventional cardiologists' knowledge and attitudes toward pharmacogenetic (PGx) testing influenced their antiplatelet prescribing decisions in response to CYP2C19 results. Materials & methods: Surveys were administered prior to participating in a randomized trial of CYP2C19 testing. Associations between baseline knowledge/attitudes and agreement with the genotype-guided antiplatelet...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Attitude
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pharmacogenetics

Share to Pharmacogenomic Testing

Source

Identifiers

PMID: 34881641
DOI: 10.2217/pme-2021-0088

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Interventional cardiologists' attitudes towards pharmacogenetic testing and impact on antiplatelet prescribing decisions.PMID 34881641Read ↗

Perspective on CYP2C19 genotyping test among patients with acute coronary syndrome - a qualitative study.Semantic proximity Read ↗

Physician response to implementation of genotype-tailored antiplatelet therapy.Semantic proximity Read ↗

Physicians’ Attitudes Toward Pharmacogenetic Testing Before and After Pharmacogenetic EducationSemantic proximity Read ↗

Survey of genetic counselors and clinical geneticists' use and attitudes toward pharmacogenetic testingSemantic proximity Read ↗

Projected impact of a multigene pharmacogenetic test to optimize medication prescribing in cardiovascular patients.Semantic proximity Read ↗

Survey on Warfarin Pharmacogenetic Testing among Anticoagulation ProvidersSemantic proximity Read ↗

Knowledge, Attitudes and Demand Toward Cardiovascular Polygenic Risk Testing in Clinical Practice: Cross-Sectional Survey of PatientsSemantic proximity Read ↗

Consumers' views of pharmacogenetics—A qualitative studySemantic proximity Read ↗

Impact of CYP2C19 genetic testing on provider prescribing patterns for antiplatelet therapy after acute coronary syndromes and percutaneous coronary intervention.Semantic proximity Read ↗

Knowledge, attitudes and demand toward cardiovascular polygenic risk testing in clinical practice: cross-sectional survey of patients.Semantic proximity Read ↗

Implementation of Pharmacogenetics in First-Line Care: Evaluation of Its Use by General PractitionersSemantic proximity Read ↗

International survey of patients undergoing percutaneous coronary intervention and their attitudes toward pharmacogenetic testingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.